FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2043580184> ?p ?o ?g. }

• W2043580184 endingPage "140" @default.
• W2043580184 startingPage "135" @default.
• W2043580184 abstract "In Brief Rofecoxib is a selective cyclooxygenase-2 inhibitor that reduces pain and inflammation without inhibiting platelet function. We examined its effects on effort-dependent pain, postoperative morphine requirements, and pulmonary function in 48 patients recovering from open abdominal surgery. Spirometric measurement of forced expiratory volume1 and vital capacity (FVC) were assessed preoperatively. One hour before the induction of a standardized general anesthetic, patients were given either placebo oral suspension (Group A), or rofecoxib oral suspension (25 mg [Group B] or 50 mg [Group C]) in a double-blinded manner. Postoperative pain control was provided with IV morphine in the postanesthesia care unit and IV-patient-controlled analgesia morphine on the patient care unit. Morphine dose, pain intensity at rest, and pain after respiratory effort (postoperative spirometry) were assessed at 12 and 24 h after study drug administration. The patient-controlled analgesia morphine dose at 24 h was reduced 44% in Group B (30.3 ± 17.5 mg) and 59% in Group C (22.1 ± 16.5 mg) versus Group A (53.7 ± 31.1 mg); P < 0.01 (A versus B). At 12 h, pain scores at rest and after spirometry were lower in Groups B and C than in A (P < 0.05). At 24 h, resting pain scores were lowest in Group C (P < 0.05). Twelve-hour FVC was best preserved in Group C (P < 0.03). There were no inter-group differences in adverse effects or perioperative blood loss. Rofecoxib oral suspension provided a morphine-sparing effect, as well as improvements in pain control and 12-h FVC in patients recovering from open abdominal surgery. IMPLICATIONS: Rofecoxib belongs to class of analgesics known as cyclooxygenase-2 inhibitors that reduce pain and inflammation with less risk of bleeding than standard nonsteroidal antiinflammatory drugs. We found that patients treated with rofecoxib 25 or 50 mg before open abdominal surgery required less IV morphine during the first day of recovery. Despite reductions in morphine requirements, rofecoxib-treated patients reported lower pain intensity scores at rest and after a vigorous cough. In the 50-mg group, improvements in pain control correlated with greater preservation of baseline cough effectiveness (vital capacity) at 12 h. These findings may offer clinical advantages in patients with preexisting pulmonary disease." @default.
• W2043580184 created "2016-06-24" @default.
• W2043580184 creator A5023202712 @default.
• W2043580184 creator A5039992227 @default.
• W2043580184 creator A5049636912 @default.
• W2043580184 creator A5060523757 @default.
• W2043580184 creator A5075385986 @default.
• W2043580184 date "2004-01-01" @default.
• W2043580184 modified "2023-10-11" @default.
• W2043580184 title "Preoperative Rofecoxib Oral Suspension as an Analgesic Adjunct After Lower Abdominal Surgery: The Effects on Effort-Dependent Pain and Pulmonary Function" @default.
• W2043580184 cites W117430661 @default.
• W2043580184 cites W1970552956 @default.
• W2043580184 cites W1978575791 @default.
• W2043580184 cites W1981662925 @default.
• W2043580184 cites W2014323425 @default.
• W2043580184 cites W2016464855 @default.
• W2043580184 cites W2021313793 @default.
• W2043580184 cites W2022574288 @default.
• W2043580184 cites W2027806727 @default.
• W2043580184 cites W2041674509 @default.
• W2043580184 cites W2043727245 @default.
• W2043580184 cites W2048543716 @default.
• W2043580184 cites W2067296619 @default.
• W2043580184 cites W2072266713 @default.
• W2043580184 cites W2080167604 @default.
• W2043580184 cites W2084156740 @default.
• W2043580184 cites W2097143372 @default.
• W2043580184 cites W2123839799 @default.
• W2043580184 cites W2154493320 @default.
• W2043580184 cites W2160566427 @default.
• W2043580184 cites W2966436114 @default.
• W2043580184 cites W4292059951 @default.
• W2043580184 doi "https://doi.org/10.1213/01.ane.0000085637.00864.d7" @default.
• W2043580184 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/14693607" @default.
• W2043580184 hasPublicationYear "2004" @default.
• W2043580184 type Work @default.
• W2043580184 sameAs 2043580184 @default.
• W2043580184 citedByCount "49" @default.
• W2043580184 countsByYear W20435801842014 @default.
• W2043580184 countsByYear W20435801842015 @default.
• W2043580184 countsByYear W20435801842016 @default.
• W2043580184 countsByYear W20435801842017 @default.
• W2043580184 countsByYear W20435801842020 @default.
• W2043580184 countsByYear W20435801842022 @default.
• W2043580184 crossrefType "journal-article" @default.
• W2043580184 hasAuthorship W2043580184A5023202712 @default.
• W2043580184 hasAuthorship W2043580184A5039992227 @default.
• W2043580184 hasAuthorship W2043580184A5049636912 @default.
• W2043580184 hasAuthorship W2043580184A5060523757 @default.
• W2043580184 hasAuthorship W2043580184A5075385986 @default.
• W2043580184 hasBestOaLocation W20435801841 @default.
• W2043580184 hasConcept C126322002 @default.
• W2043580184 hasConcept C141071460 @default.
• W2043580184 hasConcept C142724271 @default.
• W2043580184 hasConcept C181199279 @default.
• W2043580184 hasConcept C185592680 @default.
• W2043580184 hasConcept C197934379 @default.
• W2043580184 hasConcept C204787440 @default.
• W2043580184 hasConcept C27081682 @default.
• W2043580184 hasConcept C2776042228 @default.
• W2043580184 hasConcept C2777389121 @default.
• W2043580184 hasConcept C2778300832 @default.
• W2043580184 hasConcept C2778582115 @default.
• W2043580184 hasConcept C2779689624 @default.
• W2043580184 hasConcept C2780120127 @default.
• W2043580184 hasConcept C2780333948 @default.
• W2043580184 hasConcept C2780820201 @default.
• W2043580184 hasConcept C31174226 @default.
• W2043580184 hasConcept C42219234 @default.
• W2043580184 hasConcept C55493867 @default.
• W2043580184 hasConcept C71924100 @default.
• W2043580184 hasConceptScore W2043580184C126322002 @default.
• W2043580184 hasConceptScore W2043580184C141071460 @default.
• W2043580184 hasConceptScore W2043580184C142724271 @default.
• W2043580184 hasConceptScore W2043580184C181199279 @default.
• W2043580184 hasConceptScore W2043580184C185592680 @default.
• W2043580184 hasConceptScore W2043580184C197934379 @default.
• W2043580184 hasConceptScore W2043580184C204787440 @default.
• W2043580184 hasConceptScore W2043580184C27081682 @default.
• W2043580184 hasConceptScore W2043580184C2776042228 @default.
• W2043580184 hasConceptScore W2043580184C2777389121 @default.
• W2043580184 hasConceptScore W2043580184C2778300832 @default.
• W2043580184 hasConceptScore W2043580184C2778582115 @default.
• W2043580184 hasConceptScore W2043580184C2779689624 @default.
• W2043580184 hasConceptScore W2043580184C2780120127 @default.
• W2043580184 hasConceptScore W2043580184C2780333948 @default.
• W2043580184 hasConceptScore W2043580184C2780820201 @default.
• W2043580184 hasConceptScore W2043580184C31174226 @default.
• W2043580184 hasConceptScore W2043580184C42219234 @default.
• W2043580184 hasConceptScore W2043580184C55493867 @default.
• W2043580184 hasConceptScore W2043580184C71924100 @default.
• W2043580184 hasLocation W20435801841 @default.
• W2043580184 hasLocation W20435801842 @default.
• W2043580184 hasOpenAccess W2043580184 @default.
• W2043580184 hasPrimaryLocation W20435801841 @default.
• W2043580184 hasRelatedWork W1966183098 @default.
• W2043580184 hasRelatedWork W2017932828 @default.
• W2043580184 hasRelatedWork W2039639245 @default.

• next